title: Molecular characterisation of murine acute myeloid leukaemia induced by 56Fe ion and 137Cs gamma ray irradiation.
abstract: Exposure to sparsely ionising gamma- or X-ray irradiation is known to increase the risk of leukaemia in humans. However, heavy ion radiotherapy and extended space exploration will expose humans to densely ionising high linear energy transfer (LET) radiation for which there is currently no understanding of leukaemia risk. Murine models have implicated chromosomal deletion that includes the hematopoietic transcription factor gene, PU.1 (Sfpi1), and point mutation of the second PU.1 allele as the primary cause of low-LET radiation-induced murine acute myeloid leukaemia (rAML). Using array comparative genomic hybridisation, fluorescence in situ hybridisation and high resolution melt analysis, we have confirmed that biallelic PU.1 mutations are common in low-LET rAML, occurring in 88% of samples. Biallelic PU.1 mutations were also detected in the majority of high-LET rAML samples. Microsatellite instability was identified in 42% of all rAML samples, and 89% of samples carried increased microsatellite mutant frequencies at the single-cell level, indicative of ongoing instability. Instability was also observed cytogenetically as a 2-fold increase in chromatid-type aberrations. These data highlight the similarities in molecular characteristics of high-LET and low-LET rAML and confirm the presence of ongoing chromosomal and microsatellite instability in murine rAML.
authors.affiliation: Genetic Analysis Group, Promega Corporation, Madison, WI, USA.
authors.forename: Leta S
authors.initials: LS
authors.lastname: Steffen
authors.forename: Jeffery W
authors.initials: JW
authors.lastname: Bacher
authors.forename: Yuanlin
authors.initials: Y
authors.lastname: Peng
authors.forename: Phuong N
authors.initials: PN
authors.lastname: Le
authors.forename: Liang-Hao
authors.initials: LH
authors.lastname: Ding
authors.forename: Paula C
authors.initials: PC
authors.lastname: Genik
authors.forename: F Andrew
authors.initials: FA
authors.lastname: Ray
authors.forename: Joel S
authors.initials: JS
authors.lastname: Bedford
authors.forename: Christina M
authors.initials: CM
authors.lastname: Fallgren
authors.forename: Susan M
authors.initials: SM
authors.lastname: Bailey
authors.forename: Robert L
authors.initials: RL
authors.lastname: Ullrich
authors.forename: Michael M
authors.initials: MM
authors.lastname: Weil
authors.forename: Michael D
authors.initials: MD
authors.lastname: Story
mesh_terms: D000818:Animals; D002588:Cesium Radioisotopes; D002842:Chromatids / Q000528:radiation effects; D002869:Chromosome Aberrations; D004307:Dose-Response Relationship, Radiation; D005720:Gamma Rays / Q000009:adverse effects*; D017404:In Situ Hybridization, Fluorescence; D007501:Iron; D015470:Leukemia, Myeloid, Acute / Q000209:etiology* / Q000235:genetics; D007953:Leukemia, Radiation-Induced / Q000235:genetics; D018499:Linear Energy Transfer; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D053842:Microsatellite Instability; D009154:Mutation; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D059010:Single-Cell Analysis; D015534:Trans-Activators / Q000235:genetics*; D000099232:Proto-Oncogene Protein Spi-1
chemical_list: D002588:Cesium Radioisotopes; D007501:Iron; D011518:Proto-Oncogene Proteins; D015534:Trans-Activators; D000099232:Proto-Oncogene Protein Spi-1